College of Medicine, Taipei Medical University, Taipei, Taiwan.
College of Medicine, National Taiwan University, Taipei, Taiwan.
Indian J Ophthalmol. 2024 Nov 1;72(Suppl 5):S919-S922. doi: 10.4103/IJO.IJO_2589_23. Epub 2024 Aug 14.
To propose a needle aspiration technique for the surgical removal of orbital cavernous hemangioma. In this retrospective case series, we enrolled 13 patients with orbital cavernous hemangioma, who underwent excisional surgery assisted with needle aspiration technique from June 2013 to April 2022. Preoperative symptoms, clinical examination, and imaging features were recorded. Surgical outcomes, including the improvement of visual acuity, proptosis, and ocular motility, were assessed. Postoperative complications were also reported. There were 11 female and two male patients, with a mean age of 50.2 ± 8.0 years (range: 38-61 years). The most common symptom was proptosis (12 cases, 92%), followed by blurred vision (6 cases, 46%). The diameter of the lesions was between 1.8 and 3.2 cm on preoperative imaging. The surgical approaches included sub-brow orbitotomy in 11 patients and the inferior transconjunctival approach in two cases. All the tumors were removed successfully after needle aspiration of 1-3 cc of intralesional blood to reduce the tumor size. Preoperative proptosis, blurred vision, and diplopia improved after the surgery in all cases. There were no serious complications or recurrence of orbital hemangioma. The study presented an effective application of the needle aspiration technique in the surgical management of orbital cavernous hemangioma. Such an innovative method can bring significant benefits, especially for those with large cavernous hemangioma within the deep orbital region.
提出一种用于手术切除眼眶海绵状血管瘤的针吸技术。在这项回顾性病例系列研究中，我们纳入了 2013 年 6 月至 2022 年 4 月期间接受针吸辅助切除术治疗的 13 例眼眶海绵状血管瘤患者。记录了术前症状、临床检查和影像学特征。评估了手术结果，包括视力、眼球突出度和眼球运动的改善。还报告了术后并发症。患者中 11 例为女性，2 例为男性，平均年龄为 50.2 ± 8.0 岁（范围：38-61 岁）。最常见的症状是眼球突出（12 例，92%），其次是视力模糊（6 例，46%）。术前影像学上病变直径为 1.8-3.2cm。手术入路包括 11 例经眉弓眶切开术和 2 例经下经结膜入路。所有肿瘤在经皮抽吸 1-3cc 瘤内血液以缩小肿瘤体积后均成功切除。所有患者的术前眼球突出度、视力模糊和复视在手术后均得到改善。无严重并发症或眼眶血管瘤复发。本研究提出了一种在眼眶海绵状血管瘤的外科治疗中应用针吸技术的有效方法。这种创新的方法特别适用于深部眼眶内大的海绵状血管瘤患者。
